Literature DB >> 11083923

The human preprotachykinin-A gene promoter has been highly conserved and can drive human-like marker gene expression in the adult mouse CNS.

A MacKenzie1, C Payne, S Boyle, A R Clarke, J P Quinn.   

Abstract

Toward an understanding of the mechanisms controlling Preprotachykinin-A (PPTA) transcription, we introduced a 380-kb human yeast artificial chromosome containing the PPTA gene tagged with the beta-galactosidase gene into transgenic mice. This resulted in a pattern of LacZ expression in the central nervous system (CNS) remarkably similar to that reported for PPTA mRNA in the rat. However, the human gene drove expression in areas of the mouse CNS not associated with strong PPTA expression in rodents but which have been shown to express PPTA in the human. This study clearly demonstrates the high degree of conservation of the mechanisms involved in PPTA transcription that has occurred throughout 100 million of divergent human and rodent evolution. This study also defines the maximum linear extent of the human PPT-A promoter. We believe these findings constitute the removal of a significant obstacle in studying the transcriptional regulation of the human PPTA gene in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083923     DOI: 10.1006/mcne.2000.0902

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  5 in total

1.  Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neurones.

Authors:  Lynne Shanley; Scott Davidson; Marissa Lear; Anil Kumar Thotakura; Iain Joseph McEwan; Ruth A Ross; Alasdair MacKenzie
Journal:  Neurosignals       Date:  2010-12-16

2.  A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.

Authors:  Camila Guindalini; Mark Howard; Kate Haddley; Ronaldo Laranjeira; David Collier; Nik Ammar; Ian Craig; Colin O'Gara; Vivian J Bubb; Tiffany Greenwood; John Kelsoe; Phil Asherson; Robin M Murray; Adauto Castelo; John P Quinn; Homero Vallada; Gerome Breen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

3.  Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.

Authors:  Gemma Nicoll; Scott Davidson; Lynne Shanley; Ben Hing; Marissa Lear; Peter McGuffin; Ruth Ross; Alasdair MacKenzie
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

4.  Induction of tachykinin production in airway epithelia in response to viral infection.

Authors:  James P Stewart; Anja Kipar; Helen Cox; Catherine Payne; Sylvia Vasiliou; John P Quinn
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

5.  SVA retrotransposons as modulators of gene expression.

Authors:  John P Quinn; Vivien J Bubb
Journal:  Mob Genet Elements       Date:  2014-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.